Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 473

1.

Subacute sensory neuronopathy and cancer: the identification of paraneoplastic syndromes.

Kiernan MC, Cornblath DR.

J Neurol Neurosurg Psychiatry. 2020 Apr 3. pii: jnnp-2020-323171. doi: 10.1136/jnnp-2020-323171. [Epub ahead of print] No abstract available.

PMID:
32245767
2.

Interneuronal networks mediate cortical inhibition and facilitation.

Higashihara M, Van den Bos MAJ, Menon P, Kiernan MC, Vucic S.

Clin Neurophysiol. 2020 Mar 3;131(5):1000-1010. doi: 10.1016/j.clinph.2020.02.012. [Epub ahead of print]

PMID:
32193161
3.

Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review.

Wan HWY, Carey KA, D'Silva A, Vucic S, Kiernan MC, Kasparian NA, Farrar MA.

Orphanet J Rare Dis. 2020 Mar 12;15(1):70. doi: 10.1186/s13023-020-1339-3. Review.

4.

Queen Square: a history of the National Hospital and its Institute of Neurology.

Kiernan MC.

J Neurol Neurosurg Psychiatry. 2020 Mar 4. pii: jnnp-2020-322776. doi: 10.1136/jnnp-2020-322776. [Epub ahead of print] No abstract available.

PMID:
32132226
5.

The Journal of Neurology, Neurosurgery and Psychiatry centenary milestone award 2020.

Kiernan MC.

J Neurol Neurosurg Psychiatry. 2020 Mar 2. pii: jnnp-2020-322976. doi: 10.1136/jnnp-2020-322976. [Epub ahead of print] No abstract available.

PMID:
32123039
6.

Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis.

Tu S, Wang C, Menke RAL, Talbot K, Barnett M, Kiernan MC, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2020 Feb 28:1-7. doi: 10.1080/21678421.2020.1733020. [Epub ahead of print]

PMID:
32106716
7.

ALS is a multistep process in South Korean, Japanese, and Australian patients.

Vucic S, Higashihara M, Sobue G, Atsuta N, Doi Y, Kuwabara S, Kim SH, Kim I, Oh KW, Park J, Kim EM, Talman P, Menon P, Kiernan MC; PACTALS Consortium.

Neurology. 2020 Feb 18. pii: 10.1212/WNL.0000000000009015. doi: 10.1212/WNL.0000000000009015. [Epub ahead of print]

PMID:
32071166
8.

Changes in long term peripheral nerve biophysical properties in childhood cancer survivors following neurotoxic chemotherapy.

Kandula T, Farrar MA, Cohn RJ, Carey KA, Johnston K, Kiernan MC, Krishnan AV, Park SB.

Clin Neurophysiol. 2020 Apr;131(4):783-790. doi: 10.1016/j.clinph.2019.12.411. Epub 2020 Jan 28.

PMID:
32066096
9.

Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis.

Swash M, Burke D, Turner MR, Grosskreutz J, Leigh PN, deCarvalho M, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):227-234. doi: 10.1136/jnnp-2019-321938. No abstract available.

PMID:
32054724
10.

The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis.

Huynh W, Ahmed R, Mahoney CJ, Nguyen C, Tu S, Caga J, Loh P, Lin CS, Kiernan MC.

Expert Rev Neurother. 2020 Mar;20(3):281-293. doi: 10.1080/14737175.2020.1727740. Epub 2020 Feb 14.

PMID:
32031423
11.

Primary lateral sclerosis: consensus diagnostic criteria.

Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, Ravits J, Silani V, Simmons Z, Statland J, van den Berg LH; Delegates of the 2nd International PLS Conference, Mitsumoto H.

J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):373-377. doi: 10.1136/jnnp-2019-322541. Epub 2020 Feb 6.

12.

Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant).

Vucic S, Ryder J, Mekhael L, Rd H, Mathers S, Needham M, Dw S, Mc K; TEALS study group.

Medicine (Baltimore). 2020 Feb;99(6):e18904. doi: 10.1097/MD.0000000000018904.

13.

Early focality and spread of cortical dysfunction in amyotrophic lateral sclerosis: A regional study across the motor cortices.

Dharmadasa T, Matamala JM, Howells J, Vucic S, Kiernan MC.

Clin Neurophysiol. 2020 Apr;131(4):958-966. doi: 10.1016/j.clinph.2019.11.057. Epub 2019 Dec 23.

PMID:
31959568
14.

Expanding the availability of medications for amyotrophic lateral sclerosis in Australia.

Mahoney CJ, Kiernan MC.

Med J Aust. 2020 Mar;212(4):189-189.e1. doi: 10.5694/mja2.50482. Epub 2020 Jan 15. No abstract available.

PMID:
31944304
15.

Taxane-induced peripheral neuropathy: differences in patient report and objective assessment.

Timmins HC, Li T, Kiernan MC, Baron-Hay S, Marx G, Boyle F, Goldstein D, Park SB.

Support Care Cancer. 2020 Jan 11. doi: 10.1007/s00520-020-05299-y. [Epub ahead of print]

PMID:
31925531
16.

Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials.

Li T, Timmins HC, King T, Kiernan MC, Goldstein D, Park SB.

Hematol Oncol. 2019 Dec 24. doi: 10.1002/hon.2706. [Epub ahead of print] Review.

PMID:
31873944
17.

Jewels in the crown: a century of achievement for the Journal of Neurology, Neurosurgery & Psychiatry.

Kiernan MC.

J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):1-2. doi: 10.1136/jnnp-2019-322443. No abstract available.

PMID:
31848227
18.

Respiratory function and cognitive profile in amyotrophic lateral sclerosis.

Huynh W, Sharplin LE, Caga J, Highton-Williamson E, Kiernan MC.

Eur J Neurol. 2020 Apr;27(4):685-691. doi: 10.1111/ene.14130. Epub 2019 Dec 11.

PMID:
31750604
19.

COG-01 Phenotypic variation in 
ALS-FTD and effect on survival.

Ahmed RM, Devenney EM, Strikwerda-Brown C, Hodges JR, Piguet O, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):301-308. doi: 10.1080/21678421.2019.1647000.

PMID:
31702468
20.

Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.

McCann EP, Fifita JA, Grima N, Galper J, Mehta P, Freckleton SE, Zhang KY, Henden L, Hogan AL, Chan Moi Fat S, Wu SS, Jagaraj CJ, Berning BA, Williams KL, Twine NA, Bauer D, Piguet O, Hodges J, Kwok JBJ, Halliday GM, Kiernan MC, Atkin J, Rowe DB, Nicholson GA, Walker AK, Blair IP, Yang S.

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):162-171. doi: 10.1136/jnnp-2019-321790. Epub 2019 Nov 5.

PMID:
31690696
21.

Sound of the crowd: wisdom of neurologists revisited.

Dharmadasa T, Kiernan MC.

Pract Neurol. 2019 Dec;19(6):552. doi: 10.1136/practneurol-2019-002384. Epub 2019 Oct 24. No abstract available.

PMID:
31649104
22.

Inherited Neuropathies.

Carroll AS, Burns J, Nicholson G, Kiernan MC, Vucic S.

Semin Neurol. 2019 Oct;39(5):620-639. doi: 10.1055/s-0039-1693006. Epub 2019 Oct 22.

PMID:
31639845
23.

TDP-43 levels in the brain tissue of ALS cases with and without C9ORF72 or ATXN2 gene expansions.

Yang Y, Halliday GM, Kiernan MC, Tan RH.

Neurology. 2019 Nov 5;93(19):e1748-e1755. doi: 10.1212/WNL.0000000000008439. Epub 2019 Oct 16.

PMID:
31619481
24.

Milestones.

Kiernan MC.

J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1189. doi: 10.1136/jnnp-2019-321711. Epub 2019 Oct 3. No abstract available.

PMID:
31582463
25.

Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients.

Issar T, Arnold R, Kwai NCG, Walker S, Yan A, Borire AA, Poynten AM, Pussell BA, Endre ZH, Kiernan MC, Krishnan AV.

Clin Neurophysiol. 2019 Nov;130(11):2088-2095. doi: 10.1016/j.clinph.2019.08.005. Epub 2019 Aug 22.

PMID:
31541986
26.

Multifocal motor neuropathy: controversies and priorities.

Yeh WZ, Dyck PJ, van den Berg LH, Kiernan MC, Taylor BV.

J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):140-148. doi: 10.1136/jnnp-2019-321532. Epub 2019 Sep 11. Review.

PMID:
31511307
27.

Measurement of axonal excitability: Consensus guidelines.

Kiernan MC, Bostock H, Park SB, Kaji R, Krarup C, Krishnan AV, Kuwabara S, Lin CS, Misawa S, Moldovan M, Sung J, Vucic S, Wainger BJ, Waxman S, Burke D.

Clin Neurophysiol. 2020 Jan;131(1):308-323. doi: 10.1016/j.clinph.2019.07.023. Epub 2019 Aug 2. Review.

28.

Neural networks associated with body composition in frontotemporal dementia.

Ahmed RM, Landin-Romero R, Liang CT, Keogh JM, Henning E, Strikwerda-Brown C, Devenney EM, Hodges JR, Kiernan MC, Farooqi IS, Piguet O.

Ann Clin Transl Neurol. 2019 Sep;6(9):1707-1717. doi: 10.1002/acn3.50869. Epub 2019 Aug 28.

29.

Regional motor cortex dysfunction in amyotrophic lateral sclerosis.

Menon P, Yiannikas C, Kiernan MC, Vucic S.

Ann Clin Transl Neurol. 2019 Aug;6(8):1373-1382. doi: 10.1002/acn3.50819. Epub 2019 Jun 28.

30.

CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Ke YD, Chan G, Stefanoska K, Au C, Bi M, Müller J, Przybyla M, Feiten A, Prikas E, Halliday GM, Piguet O, Kiernan MC, Kassiou M, Hodges JR, Loy CT, Mattick JS, Ittner A, Kril JJ, Sutherland GT, Ittner LM.

J Biol Chem. 2019 Sep 20;294(38):14149-14162. doi: 10.1074/jbc.RA118.005263. Epub 2019 Jul 31.

PMID:
31366728
31.

Consensus for experimental design in electromyography (CEDE) project: Electrode selection matrix.

Besomi M, Hodges PW, Van Dieën J, Carson RG, Clancy EA, Disselhorst-Klug C, Holobar A, Hug F, Kiernan MC, Lowery M, McGill K, Merletti R, Perreault E, Søgaard K, Tucker K, Besier T, Enoka R, Falla D, Farina D, Gandevia S, Rothwell JC, Vicenzino B, Wrigley T.

J Electromyogr Kinesiol. 2019 Oct;48:128-144. doi: 10.1016/j.jelekin.2019.07.008. Epub 2019 Jul 19.

PMID:
31352156
32.

Sonographic assessment of nerve blood flow in diabetic neuropathy.

Borire AA, Issar T, Kwai NC, Visser LH, Simon NG, Poynten AM, Kiernan MC, Krishnan AV.

Diabet Med. 2020 Feb;37(2):343-349. doi: 10.1111/dme.14085. Epub 2019 Aug 2.

PMID:
31338857
33.

Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients.

Timmins HC, Li T, Kiernan MC, Horvath LG, Goldstein D, Park SB.

J Pain. 2019 Jul 17. pii: S1526-5900(19)30765-5. doi: 10.1016/j.jpain.2019.06.011. [Epub ahead of print] Review.

PMID:
31325646
34.

Neuroinflammation in frontotemporal dementia.

Bright F, Werry EL, Dobson-Stone C, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kassiou M, Kril JJ.

Nat Rev Neurol. 2019 Sep;15(9):540-555. doi: 10.1038/s41582-019-0231-z. Epub 2019 Jul 19. Review.

PMID:
31324897
35.

Motor neuron disease with malignancy: Clinical and pathophysiological insights.

Higashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S.

Clin Neurophysiol. 2019 Sep;130(9):1557-1561. doi: 10.1016/j.clinph.2019.05.026. Epub 2019 Jun 22.

PMID:
31301633
36.

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.

Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):595-604. doi: 10.1080/21678421.2019.1632899. Epub 2019 Jul 8.

PMID:
31284774
37.

Amyotrophic lateral sclerosis as a multi-step process: an Australia population study.

Vucic S, Westeneng HJ, Al-Chalabi A, Van Den Berg LH, Talman P, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):532-537. doi: 10.1080/21678421.2018.1556697. Epub 2019 Jul 8.

PMID:
31284763
38.

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.

Werry EL, Bright FM, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kril JJ, Kassiou M.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3161. doi: 10.3390/ijms20133161. Review.

39.

Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period.

Kiernan MC, Ziemann U, Eisen A.

Muscle Nerve. 2019 Sep;60(3):232-235. doi: 10.1002/mus.26617. Epub 2019 Jul 5. Review.

PMID:
31233613
40.

Marco Polo of Australian neurology.

Kiernan MC, Goadsby PJ, Burke D.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):627-628. doi: 10.1136/jnnp-2019-320989. Epub 2019 May 2. No abstract available.

PMID:
31048340
41.

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia.

Ahmed RM, Phan K, Highton-Williamson E, Strikwerda-Brown C, Caga J, Ramsey E, Zoing M, Devenney E, Kim WS, Hodges JR, Piguet O, Halliday GM, Kiernan MC.

Ann Clin Transl Neurol. 2019 Jan 31;6(3):486-495. doi: 10.1002/acn3.721. eCollection 2019 Mar.

42.

Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.

Garg N, Park SB, Howells J, Vucic S, Yiannikas C, Mathey EK, Nguyen T, Noto Y, Barnett MH, Krishnan AV, Spies J, Bostock H, Pollard JD, Kiernan MC.

Eur J Neurol. 2019 Aug;26(8):1121-1129. doi: 10.1111/ene.13953. Epub 2019 Apr 26.

PMID:
30882969
43.

The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability.

Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC, Hodges JR, Piguet O, Halliday GM.

Neurology. 2019 Mar 19;92(12):e1354-e1366. doi: 10.1212/WNL.0000000000007146. Epub 2019 Feb 15.

PMID:
30770429
44.

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis.

McMackin R, Muthuraman M, Groppa S, Babiloni C, Taylor JP, Kiernan MC, Nasseroleslami B, Hardiman O.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1011-1020. doi: 10.1136/jnnp-2018-319581. Epub 2019 Feb 13. Review.

45.

The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS.

Dharmadasa T, Matamala JM, Howells J, Simon NG, Vucic S, Kiernan MC.

Neurosci Lett. 2019 Apr 23;699:84-90. doi: 10.1016/j.neulet.2019.01.050. Epub 2019 Jan 30.

PMID:
30710665
46.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
47.

Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Long Z, Irish M, Piguet O, Kiernan MC, Hodges JR, Burrell JR.

J Neurol. 2019 Apr;266(4):921-933. doi: 10.1007/s00415-019-09216-0. Epub 2019 Feb 1.

PMID:
30707358
48.

Vasculitic neuropathy: Comparison of clinical predictors with histopathological outcome.

Nathani D, Barnett MH, Spies J, Pollard J, Wang MX, Kiernan MC.

Muscle Nerve. 2019 Jun;59(6):643-649. doi: 10.1002/mus.26431. Epub 2019 Feb 23.

PMID:
30702153
49.

Cerebellar tract alterations in PLS and ALS.

Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):281-284. doi: 10.1080/21678421.2018.1562554. Epub 2019 Jan 21.

PMID:
30663900
50.

Functional Biomarkers for Amyotrophic Lateral Sclerosis.

Huynh W, Dharmadasa T, Vucic S, Kiernan MC.

Front Neurol. 2019 Jan 4;9:1141. doi: 10.3389/fneur.2018.01141. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center